LEADER 01458nam  2200385Ia 450 
001 9910699125703321
005 20230902162120.0
035   $a(CKB)5470000002400642
035   $a(OCoLC)464691892
035   $a(EXLCZ)995470000002400642
100   $a20091110d1998      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $emanufacturing, processing, or holding active pharmaceutical ingredients
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[1998]
215   $a1 online resource (iii, 53 pages)
300   $a"Center for Biologics Evaluation and Research (CBER)."
300   $a"Center for Veterinary Medicine (CVM)."
300   $a"March 1998."
320   $aIncludes bibliographical references (pages 44-46).
517   $aGuidance for industry 
606   $aDrug development$xGovernment policy$zUnited States
615  0$aDrug development$xGovernment policy
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 02$aCenter for Veterinary Medicine (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699125703321
996   $aGuidance for industry$93434577
997   $aUNINA